Blogs and News

Clinical trials come with vast amounts of information, and a new partnership between Siron Clinical and Montrium will ensure clients benefit from efficient and effective trial information management in an increasingly digitized clinical research industry.

An estimated 1 in 50 children over the age of 4 are allergic to peanuts; a new immunotherapy now approved by the FDA, following phase III trials carried out with support from Siron Clinical, will help increase their tolerance to peanuts and reduce their risk of anaphylaxis.

BIO-Europe attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. It is a unique opportunity to meet potential partners and suppliers through one-to-one meetings.

For the past 20 years, Siron Clinical has provided a high level of expertise in clinical trials for biotechs. Discover our Siron Clinical rebrand journey.

As we step into 2020, the team at Siron Clinical felt it was time to take our brand into the new decade. With 20 years of experience under our belts, we wanted to reflect that our company is also moving with the times, and ready to take on future challenges. Siron Clinical was ready to rebrand.